Matches in Wikidata for { <http://www.wikidata.org/entity/Q84816670> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q84816670 description "article scientifique publié en 2012" @default.
- Q84816670 description "artículu científicu espublizáu en xunu de 2012" @default.
- Q84816670 description "im Juni 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q84816670 description "scientific article published on 01 June 2012" @default.
- Q84816670 description "wetenschappelijk artikel" @default.
- Q84816670 description "наукова стаття, опублікована в червні 2012" @default.
- Q84816670 name "[Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?]" @default.
- Q84816670 name "[Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?]" @default.
- Q84816670 type Item @default.
- Q84816670 label "[Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?]" @default.
- Q84816670 label "[Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?]" @default.
- Q84816670 prefLabel "[Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?]" @default.
- Q84816670 prefLabel "[Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?]" @default.
- Q84816670 P1433 Q84816670-3E141F9B-3D3E-43BE-B8F2-B567939A0D47 @default.
- Q84816670 P1476 Q84816670-BA158DFB-DE09-4C38-A24B-7232389D1D44 @default.
- Q84816670 P2093 Q84816670-93700A15-4A33-4C09-93CF-C5302180D1B8 @default.
- Q84816670 P2093 Q84816670-F4E4B3D6-43A9-48D2-9DF5-CE16F934619B @default.
- Q84816670 P304 Q84816670-46A3D366-2299-485E-9D44-7F1CF6A380D9 @default.
- Q84816670 P31 Q84816670-CBD5F074-6A38-424F-85A6-57574DE70B07 @default.
- Q84816670 P433 Q84816670-44EF14CA-9CF0-433D-BBB2-918F415F91A4 @default.
- Q84816670 P478 Q84816670-31A2A3AC-6CF1-436B-83F1-FAF95189AF5C @default.
- Q84816670 P50 Q84816670-7FB8340F-49AC-4076-A081-1826A74A335E @default.
- Q84816670 P577 Q84816670-A881CAC4-C862-4AB4-BEFD-35ACB1C55A3D @default.
- Q84816670 P698 Q84816670-85C8615F-5387-4366-A08E-1AC101B21FB6 @default.
- Q84816670 P921 Q84816670-02B2BAEA-037F-451C-A037-1313DEE87ABD @default.
- Q84816670 P921 Q84816670-46775D9F-68AD-4C88-971D-124839E69109 @default.
- Q84816670 P921 Q84816670-766A0368-0CAD-4865-93ED-FAFC826E3E7D @default.
- Q84816670 P698 22900267 @default.
- Q84816670 P1433 Q26853996 @default.
- Q84816670 P1476 "[Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?]" @default.
- Q84816670 P2093 "Aimery de Gramont" @default.
- Q84816670 P2093 "Annette K Larsen" @default.
- Q84816670 P304 "607-608" @default.
- Q84816670 P31 Q13442814 @default.
- Q84816670 P433 "6" @default.
- Q84816670 P478 "99" @default.
- Q84816670 P50 Q56250413 @default.
- Q84816670 P577 "2012-06-01T00:00:00Z" @default.
- Q84816670 P698 "22900267" @default.
- Q84816670 P921 Q18555025 @default.
- Q84816670 P921 Q413299 @default.
- Q84816670 P921 Q420296 @default.